IGF-1 Receptor Differentially Regulates Spontaneous and Evoked Transmission via Mitochondria at Hippocampal Synapses

Neuron

Volumn 89, Issue 3, 2016, Pages 583-597

  Gazit, Neta ^a   Vertkin, Irena ^a   Shapira, Ilana ^a   Helm, Martin ^b,c   Slomowitz, Edden ^a   Sheiba, Maayan ^a   Mor, Yael ^a   Rizzoli, Silvio ^b   Slutsky, Inna ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c INTERNATIONAL MAX PLANCK RESEARCH SCHOOL FOR MOLECULAR BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; NEUROTRANSMITTER; SOMATOMEDIN C RECEPTOR; CALCIUM; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN NERVE CELL; BRAIN SLICE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETIC TRANSFECTION; HIPPOCAMPUS; MICROSCOPY; MITOCHONDRION; MOUSE; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPIKE; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DEFICIENCY; METABOLISM; MINIATURE ENDPLATE POTENTIAL; NERVE CELL; NERVE ENDING; PHYSIOLOGY; PRIMARY CELL CULTURE; SYNAPSE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CELLS, CULTURED; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; INSULIN-LIKE GROWTH FACTOR I; MICE; MINIATURE POSTSYNAPTIC POTENTIALS; MITOCHONDRIA; NEURONAL PLASTICITY; NEURONS; PRESYNAPTIC TERMINALS; PRIMARY CELL CULTURE; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES;

EID: 84959484667     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.12.034     Document Type: Article

References (72)

1. Abramov E., Dolev I., Fogel H., Ciccotosto G.D., Ruff E., Slutsky I. Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat. Neurosci. 2009, 12:1567-1576.
2. Adams T.E., Epa V.C., Garrett T.P.J., Ward C.W. Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 2000, 57:1050-1093.
3. Alnaes E., Rahamimoff R. On the role of mitochondria in transmitter release from motor nerve terminals. J. Physiol. 1975, 248:285-306.
4. Amaducci L., Tesco G. Aging as a major risk for degenerative diseases of the central nervous system. Curr. Opin. Neurol. 1994, 7:283-286.
5. Atasoy D., Ertunc M., Moulder K.L., Blackwell J., Chung C., Su J., Kavalali E.T. Spontaneous and evoked glutamate release activates two populations of NMDA receptors with limited overlap. J. Neurosci. 2008, 28:10151-10166.
6. Bakker A., Krauss G.L., Albert M.S., Speck C.L., Jones L.R., Stark C.E., Yassa M.A., Bassett S.S., Shelton A.L., Gallagher M. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 2012, 74:467-474.
7. Baughman J.M., Perocchi F., Girgis H.S., Plovanich M., Belcher-Timme C.A., Sancak Y., Bao X.R., Strittmatter L., Goldberger O., Bogorad R.L., et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 2011, 476:341-345.
8. Billups B., Forsythe I.D. Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses. J. Neurosci. 2002, 22:5840-5847.
9. Blair L.A.C., Marshall J. IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner. Neuron 1997, 19:421-429.
10. Boulanger L.M., Poo M.M. Presynaptic depolarization facilitates neurotrophin-induced synaptic potentiation. Nat. Neurosci. 1999, 2:346-351.
11. Cao P., Maximov A., Südhof T.C. Activity-dependent IGF-1 exocytosis is controlled by the Ca(2+)-sensor synaptotagmin-10. Cell 2011, 145:300-311.
12. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat. Med. 2002, 8:1390-1397.
13. Carro E., Trejo J.L., Spuch C., Bohl D., Heard J.M., Torres-Aleman I. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?. Neurobiol. Aging 2006, 27:1618-1631.
14. Chen T.-W., Wardill T.J., Sun Y., Pulver S.R., Renninger S.L., Baohan A., Schreiter E.R., Kerr R.A., Orger M.B., Jayaraman V., et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 2013, 499:295-300.
15. Cohen E., Dillin A. The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat. Rev. Neurosci. 2008, 9:759-767.
16. Cohen E., Paulsson J.F., Blinder P., Burstyn-Cohen T., Du D., Estepa G., Adame A., Pham H.M., Holzenberger M., Kelly J.W., et al. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 2009, 139:1157-1169.
17. D'Ercole A.J., Ye P., Calikoglu A.S., Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol. Neurobiol. 1996, 13:227-255.
18. David G., Talbot J., Barrett E.F. Quantitative estimate of mitochondrial [Ca2+] in stimulated motor nerve terminals. Cell Calcium 2003, 33:197-206.
19. De Stefani D., Raffaello A., Teardo E., Szabò I., Rizzuto R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 2011, 476:336-340.
20. Ding Q., Vaynman S., Akhavan M., Ying Z., Gomez-Pinilla F. Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience 2006, 140:823-833.
21. Dobrunz L.E., Stevens C.F. Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 1997, 18:995-1008.
22. Dolev I., Fogel H., Milshtein H., Berdichevsky Y., Lipstein N., Brose N., Gazit N., Slutsky I. Spike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change. Nat. Neurosci. 2013, 16:587-595.
23. Fernandez A.M., Torres-Alemán I. The many faces of insulin-like peptide signalling in the brain. Nat. Rev. Neurosci. 2012, 13:225-239.
24. Flier J.S., Usher P., Moses A.C. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc. Natl. Acad. Sci. USA 1986, 83:664-668.
25. Freude S., Hettich M.M., Schumann C., Stöhr O., Koch L., Köhler C., Udelhoven M., Leeser U., Müller M., Kubota N., et al. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease. FASEB J. 2009, 23:3315-3324.
26. Gao X., Zhang J. Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains. Mol. Biol. Cell 2008, 19:4366-4373.
27. Gontier G., George C., Chaker Z., Holzenberger M., Aïd S. Blocking IGF signaling in adult neurons alleviates Alzheimer's disease pathology through amyloid-β clearance. J. Neurosci. 2015, 35:11500-11513.
28. Guo X., Macleod G.T., Wellington A., Hu F., Panchumarthi S., Schoenfield M., Marin L., Charlton M.P., Atwood H.L., Zinsmaier K.E. The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 2005, 47:379-393.
29. Harris J.J., Jolivet R., Attwell D. Synaptic energy use and supply. Neuron 2012, 75:762-777.
30. Imamura H., Nhat K.P., Togawa H., Saito K., Iino R., Kato-Yamada Y., Nagai T., Noji H. Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators. Proc. Natl. Acad. Sci. USA 2009, 106:15651-15656.
31. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., Copeland N.G., Lee M.K., Younkin L.H., Wagner S.L., et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 2004, 13:159-170.
32. Kang H., Welcher A.A., Shelton D., Schuman E.M. Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation. Neuron 1997, 19:653-664.
33. Kar S., Chabot J.G., Quirion R. Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain. J. Comp. Neurol. 1993, 333:375-397.
34. Kavran J.M., McCabe J.M., Byrne P.O., Connacher M.K., Wang Z., Ramek A., Sarabipour S., Shan Y., Shaw D.E., Hristova K., et al. How IGF-1 activates its receptor. eLife 2014, 3:3.
35. Kenyon C.J. The genetics of ageing. Nature 2010, 464:504-512.
36. Koster J.C., Permutt M.A., Nichols C.G. Diabetes and insulin secretion: the ATP-sensitive K+ channel (K ATP) connection. Diabetes 2005, 54:3065-3072.
37. Landi S., Ciucci F., Maffei L., Berardi N., Cenni M.C. Setting the pace for retinal development: environmental enrichment acts through insulin-like growth factor 1 and brain-derived neurotrophic factor. J. Neurosci. 2009, 29:10809-10819.
38. Laviv T., Riven I., Dolev I., Vertkin I., Balana B., Slesinger P.A., Slutsky I. Basal GABA regulates GABA(B)R conformation and release probability at single hippocampal synapses. Neuron 2010, 67:253-267.
39. Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141:1117-1134.
40. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 1995, 16:143-163.
41. Moloney A.M., Griffin R.J., Timmons S., O'Connor R., Ravid R., O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol. Aging 2010, 31:224-243.
42. Párrizas M., Gazit A., Levitzki A., Wertheimer E., LeRoith D. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 1997, 138:1427-1433.
43. Patron M., Checchetto V., Raffaello A., Teardo E., Vecellio Reane D., Mantoan M., Granatiero V., Szabò I., De Stefani D., Rizzuto R. MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting opposite effects on MCU activity. Mol. Cell 2014, 53:726-737.
44. Peled E.S., Newman Z.L., Isacoff E.Y. Evoked and spontaneous transmission favored by distinct sets of synapses. Curr. Biol. 2014, 24:484-493.
45. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2001, 2:24-32.
46. Pozzan T., Rudolf R. Measurements of mitochondrial calcium in vivo. Biochim. Biophys. Acta. Bioenergetics 2009, 1787:1317-1323.
47. Raingo J., Khvotchev M., Liu P., Darios F., Li Y.C., Ramirez D.M., Adachi M., Lemieux P., Toth K., Davletov B., Kavalali E.T. VAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmission. Nat. Neurosci. 2012, 15:738-745.
48. Ramirez D.M., Kavalali E.T. Differential regulation of spontaneous and evoked neurotransmitter release at central synapses. Curr. Opin. Neurobiol. 2011, 21:275-282.
49. Ramsey M.M., Adams M.M., Ariwodola O.J., Sonntag W.E., Weiner J.L. Functional characterization of des-IGF-1 action at excitatory synapses in the CA1 region of rat hippocampus. J. Neurophysiol. 2005, 94:247-254.
50. Rangaraju V., Calloway N., Ryan T.A. Activity-driven local ATP synthesis is required for synaptic function. Cell 2014, 156:825-835.
51. Revelo N.H., Kamin D., Truckenbrodt S., Wong A.B., Reuter-Jessen K., Reisinger E., Moser T., Rizzoli S.O. A new probe for super-resolution imaging of membranes elucidates trafficking pathways. J. Cell Biol. 2014, 205:591-606.
52. Rizzuto R., De Stefani D., Raffaello A., Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol. 2012, 13:566-578.
53. Schumacher R., Mosthaf L., Schlessinger J., Brandenburg D., Ullrich A. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. J. Biol. Chem. 1991, 266:19288-19295.
54. Scotti A.L., Chatton J.Y., Reuter H. Roles of Na(+)-Ca2+ exchange and of mitochondria in the regulation of presynaptic Ca2+ and spontaneous glutamate release. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1999, 354:357-364.
55. Shulman Y., Stavsky A., Fedorova T., Mikulincer D., Atias M., Radinsky I., Kahn J., Slutsky I., Gitler D. ATP binding to synaspsin IIa regulates usage and clustering of vesicles in terminals of hippocampal neurons. J. Neurosci. 2015, 35:985-998.
56. Slutsky I., Sadeghpour S., Li B., Liu G. Enhancement of synaptic plasticity through chronically reduced Ca2+ flux during uncorrelated activity. Neuron 2004, 44:835-849.
57. Suh Y., Atzmon G., Cho M.-O., Hwang D., Liu B., Leahy D.J., Barzilai N., Cohen P. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl. Acad. Sci. USA 2008, 105:3438-3442.
58. Tang Y., Zucker R.S. Mitochondrial involvement in post-tetanic potentiation of synaptic transmission. Neuron 1997, 18:483-491.
59. Trejo J.L., Carro E., Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J. Neurosci. 2001, 21:1628-1634.
60. Tropea D., Kreiman G., Lyckman A., Mukherjee S., Yu H., Horng S., Sur M. Gene expression changes and molecular pathways mediating activity-dependent plasticity in visual cortex. Nat. Neurosci. 2006, 9:660-668.
61. Ullrich A., Gray A., Tam A.W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E., et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986, 5:2503-2512.
62. Vasilcanu D., Girnita A., Girnita L., Vasilcanu R., Axelson M., Larsson O. The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway. Oncogene 2004, 23:7854-7862.
63. Verstreken P., Ly C.V., Venken K.J., Koh T.W., Zhou Y., Bellen H.J. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 2005, 47:365-378.
64. Vossel K.A., Beagle A.J., Rabinovici G.D., Shu H., Lee S.E., Naasan G., Hegde M., Cornes S.B., Henry M.L., Nelson A.B., et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013, 70:1158-1166.
65. Wang G.J., Thayer S.A. NMDA-induced calcium loads recycle across the mitochondrial inner membrane of hippocampal neurons in culture. J. Neurophysiol. 2002, 87:740-749.
66. Wang H., Qin J., Gong S., Feng B., Zhang Y., Tao J. Insulin-like growth factor-1 receptor-mediated inhibition of A-type K(+) current induces sensory neuronal hyperexcitability through the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2 pathways, independently of Akt. Endocrinology 2014, 155:168-179.
67. Weiler S., Krinner S., Wong A.B., Moser T., Pangršič T. ATP hydrolysis is critically required for function of CaV1.3 channels in cochlear inner hair cells via fueling Ca2+ clearance. J. Neurosci. 2014, 34:6843-6848.
68. White R.J., Reynolds I.J. Mitochondria and Na+/Ca2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons. J. Neurosci. 1995, 15:1318-1328.
69. Wu L., Bauer C.S., Zhen X.G., Xie C., Yang J. Dual regulation of voltage-gated calcium channels by PtdIns(4,5)P2. Nature 2002, 419:947-952.
70. Xing C., Yin Y., Chang R., Gong X., He X., Xie Z. Effects of insulin-like growth factor 1 on synaptic excitability in cultured rat hippocampal neurons. Exp. Neurol. 2007, 205:222-229.
71. Yamaguchi F., Itano T., Mizobuchi M., Miyamoto O., Janjua N.A., Matsui H., Tokuda M., Ohmoto T., Hosokawa K., Hatase O. Insulin-like growth factor I (IGF-I) distribution in the tissue and extracellular compartment in different regions of rat brain. Brain Res. 1990, 533:344-347.
72. Zhang B., Tang X.C., Zhang H.Y. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models. J. Neurosci. Res. 2013, 91:717-725.